Fraunhofer IZI Services for Antibodies Fraunhofer IZI provides GMP Antibody Manufacturing Services with Sartorius Stedim Biotech single-use technologies Fraunhofer Institute for Cell Therapy and Immunology Department of Therapy Validation Leipzig, Germany Success Story In recent years, the increasing number of therapeutic monoclonal antibody candidates under preclinical and clinical development require new flexible, efficient and economic opportunities for GMP production of therapeutic antibody candidates. Small-scale batch production of test samples for late preclinical GLP animal studies or for phase-1 and phase-2 clinical studies is often not appropriate for large-scale manufacturing facilities in the industry. The Fraunhofer IZI, founded in 2005, investigates and develops

Join for free to read